Prolaris® Test Accurately Predicts Risk of Metastasis in Men Diagnosed with Localized Prostate Cancer

Ads

You May Also Like

Strongbridge Biopharma plc Announces Executive Promotion and Leadership Transition

DUBLIN, Ireland and TREVOSE, Pa., June 09, 2016 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc ...

Centering Healthcare Institute Announces Awardees for Group Care Implementation

Boston, MA, March 21, 2018 (GLOBE NEWSWIRE) -- The Centering® Healthcare Institute (CHI) today ...

Shire plc : Block listing Interim Review

BLOCK LISTING SIX MONTHLY RETURN May 23, 2018 - Shire plc (LSE: SHP, NASDAQ: ...